PharmaCyte Biotech Inc (PMCB)

[Otsy]

Bull, In addition, Gilead's new drug, Sovaldi has been reported to be working wonders and is being approved by almost all insurance companies, in the USA, for all those who for some medical reason (of which there are many) who cannot take interferon or riboviron. It's flying off the shelves. I purchased Gilead at 30 before the split and sold at 82 after the split, just before it started to tank. I have followed GILD for over a year before investing and other than being a pink, and all that goes with that, has a lot of similarities to NVLX, in my opinion, except that, in the hep c drug case, there is a lot down the pipeline. I don't hear of anything down the cell encapsulation pipeline that is significant. Bio-techs dumped due to fear recently and will rise to above expectations, again that is in my humble opinion. There seems to be a lot of excitement expected down the road in the "not too distant future" in Pharmaceuticals and delivery techniques due to inroads made in many aspects of medical research.